scispace - formally typeset
M

Megan E. Miller

Researcher at Case Western Reserve University

Publications -  50
Citations -  3442

Megan E. Miller is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 11, co-authored 32 publications receiving 2928 citations. Previous affiliations of Megan E. Miller include University of Chicago & American College of Surgeons.

Papers
More filters
Journal ArticleDOI

Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial.

TL;DR: A strategy for whole-body rehabilitation-consisting of interruption of sedation and physical and occupational therapy in the earliest days of critical illness-was safe and well tolerated, and resulted in better functional outcomes at hospital discharge, a shorter duration of delirium, and more ventilator-free days compared with standard care.
Journal ArticleDOI

Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation.

TL;DR: Early physical and occupational therapy is feasible from the onset of mechanical ventilation despite high illness acuity and presence of life support devices, and adverse events related to this intervention are uncommon.
Journal ArticleDOI

The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events

TL;DR: It is shown that exposure of non-transgenic primary cortical neurons to Aβ oligomers, but not monomers or fibrils, results in the retraction of neuronal processes, and induction of CCEs in a concentration dependent manner.
Journal ArticleDOI

Operative Risks Associated with Contralateral Prophylactic Mastectomy: A Single Institution Experience

TL;DR: CPM patients have an increased risk of complications, especially major complications requiring rehospitalization or reoperation, and these complications may influence patient and physician decisions to choose CPM.
Journal ArticleDOI

Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation Therapy

TL;DR: Among men with nonmetastatic prostate cancer receiving ADT, once-weekly alendronate improves bone density and decreases turnover, whereas discontinuation results in bone loss and increased bone turnover.